Related Experiment Video
Updated: Feb 27, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia
Masanori Hayashi1, Agustin Calatroni, Brittany Herzberg
1Department of Pediatrics, Division of Hematology/Oncology, Duke University Medical Center, Durham, NC, USA.
Insights
Children with sickle cell anemia on hydroxyurea require fewer perioperative transfusions. This study found hydroxyurea use significantly reduced transfusion needs in pediatric patients undergoing surgery, with low complication rates.
Area of Science:
- Pediatric Hematology
- Surgical Management
- Sickle Cell Disease Treatment
Background:
- Sickle cell anemia (HbSS genotype) presents significant challenges in pediatric surgical care.
- Hydroxyurea is an established treatment that modifies disease severity in sickle cell anemia.
- Perioperative management, including blood transfusions, is critical for patients with sickle cell anemia.
Purpose of the Study:
- To compare perioperative transfusion requirements and outcomes in children with sickle cell anemia who were taking hydroxyurea versus those not taking it.
- To evaluate the impact of hydroxyurea on transfusion strategies in the perioperative period for pediatric patients with sickle cell disease.
Main Methods:
- Retrospective review of 51 children with sickle cell anemia (HbSS genotype) undergoing surgery between January 2003 and April 2008.
- Comparison of perioperative transfusion management (no transfusion, single transfusion, serial transfusions/pheresis) between patients on hydroxyurea and those not on hydroxyurea.
- Analysis of complication rates, including transfusion reactions and acute chest syndrome.
Main Results:
- Children taking hydroxyurea (n=30) received significantly fewer perioperative transfusions compared to those not taking hydroxyurea (n=21) (P=0.004).
- Only 27% of hydroxyurea patients required no preoperative transfusion, compared to 5% in the non-hydroxyurea group.
- While complication rates were low in both groups, one patient not on hydroxyurea experienced a delayed hyperhemolytic transfusion reaction.
Conclusions:
- Hydroxyurea therapy is associated with a substantial reduction in perioperative transfusions for children with sickle cell anemia undergoing surgery.
- Both hydroxyurea and non-hydroxyurea groups demonstrated low overall complication rates.
- Further research is warranted to optimize perioperative protocols for pediatric sickle cell anemia patients receiving hydroxyurea.
Abstract:
Hydroxyurea has enhanced the treatment for children with sickle cell anemia. The objectives of this study were to compare perioperative transfusions and outcomes for children taking hydroxyurea versus those not taking hydroxyurea. We retrospectively reviewed perioperative management and outcomes for 51 children with sickle cell anemia (HbSS genotype) who underwent surgery in our center between January 2003 and April 2008. Of the 51 patients, 30 (59%) were taking hydroxyurea and 21 (41%) were not taking hydroxyurea. Eight of 30 (27%) in the hydroxyurea group were not transfused preoperatively, 12 of 30 (40%) received a single transfusion and 10 of 30 (33%) received serial transfusions, compared with 1 of 21 (5%) children in the nonhydroxyurea group who was not transfused, 2 of 21 (10%) who received a single transfusion and 18 of 21 (85%) who received serial transfusions or pheresis (P=0.004; for comparison across groups). One patient not taking hydroxyurea developed a delayed hyperhemolytic transfusion reaction, and 2 children taking hydroxyurea developed acute chest syndrome. Overall, children taking hydroxyurea had substantially fewer transfusions compared with children not taking hydroxyurea. Both groups of children had a low complication rate. Further research should be done to optimize perioperative management of children taking hydroxyurea.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications

